ProfileGDS4718 / 223165_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 95% 94% 85% 95% 97% 90% 95% 95% 96% 97% 95% 95% 91% 95% 93% 94% 96% 93% 96% 93% 96% 96% 96% 96% 95% 95% 96% 97% 96% 88% 92% 95% 94% 94% 95% 89% 94% 95% 95% 82% 95% 95% 93% 90% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.400295
GSM549102patient 115, normal, homogenized [OPG study]10.048394
GSM549104patient 119, normal, homogenized [OPG study]8.5016385
GSM549108patient 138, normal, homogenized [OPG study]10.357995
GSM549119patient 077, normal, homogenized [OPG study]11.064897
GSM549133patient 032, cancer, homogenized [OPG study]9.3131290
GSM549139patient 042, cancer, homogenized [OPG study]10.165195
GSM549099patient 107, normal, homogenized [OPG study]10.10595
GSM549109patient 139, normal, homogenized [OPG study]10.792996
GSM549110patient 046, normal, homogenized [OPG study]11.175297
GSM549114patient 063, normal, homogenized [OPG study]10.479495
GSM549122patient 082, normal, homogenized [OPG study]10.23995
GSM549134patient 033, cancer, homogenized [OPG study]9.4483391
GSM549136patient 036, cancer, homogenized [OPG study]10.218195
GSM549140patient 044, cancer, homogenized [OPG study]9.7863493
GSM549111patient 047, normal, homogenized [OPG study]10.208194
GSM549113patient 057, normal, homogenized [OPG study]10.778996
GSM549132patient 031, cancer, homogenized [OPG study]9.6819993
GSM549137patient 038, cancer, homogenized [OPG study]10.275396
GSM549142patient 047, cancer, homogenized [OPG study]9.1902693
GSM549100patient 110, normal, homogenized [OPG study]10.650596
GSM549107patient 135, normal, homogenized [OPG study]10.671796
GSM549115patient 068, normal, homogenized [OPG study]10.807396
GSM549116patient 072, normal, homogenized [OPG study]10.770396
GSM549120patient 078, normal, homogenized [OPG study]10.345395
GSM549131patient 030, cancer, homogenized [OPG study]10.315695
GSM549118patient 074, normal, homogenized [OPG study]10.552496
GSM549129patient 027, cancer, homogenized [OPG study]10.72997
GSM549123patient 088, normal, homogenized [OPG study]10.662496
GSM549124patient 006, cancer, homogenized [OPG study]8.6872888
GSM549126patient 015, cancer, homogenized [OPG study]9.539492
GSM549128patient 025, cancer, homogenized [OPG study]10.228495
GSM549103patient 117, normal, homogenized [OPG study]10.021894
GSM549117patient 073, normal, homogenized [OPG study]10.223594
GSM549138patient 041, cancer, homogenized [OPG study]10.321895
GSM549141patient 045, cancer, homogenized [OPG study]9.0972789
GSM549130patient 028, cancer, homogenized [OPG study]9.8826594
GSM549101patient 111, normal, homogenized [OPG study]10.072695
GSM549105patient 128, normal, homogenized [OPG study]10.332695
GSM549106patient 134, normal, homogenized [OPG study]8.3178682
GSM549112patient 048, normal, homogenized [OPG study]10.420995
GSM549125patient 011, cancer, homogenized [OPG study]10.124995
GSM549127patient 024, cancer, homogenized [OPG study]9.7144293
GSM549135patient 035, cancer, homogenized [OPG study]9.2134690